Valuation: Optiscan Imaging Limited

Market Cap 125M 87.35M 76.82M 71.37M 65.64M 123M 8.46B 853M 333M 4.13B 328M 321M 14.31B P/E 2024
-31.8x
P/E 2025 -14.5x
Enterprise Value 122M 85.21M 74.94M 69.62M 64.03M 120M 8.25B 833M 325M 4.02B 320M 313M 13.96B EV / Sales 2024
62.1x
EV / Sales 2025 23.8x
Free-Float
36.32%
Yield 2024 *
-
Yield 2025 -
1 day+3.23%
1 week+3.23%
Current month+33.33%
1 month+28.00%
3 months+45.45%
6 months+77.78%
Current year+60.00%
1 week 0.14
Extreme 0.14
0.16
1 month 0.12
Extreme 0.12
0.16
Current year 0.08
Extreme 0.08
0.16
1 year 0.08
Extreme 0.079
0.16
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.29
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 2021-12-12
Director of Finance/CFO - 2025-03-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 2021-04-18
Director/Board Member - 2022-06-13
Director/Board Member - 2021-07-28
Date Insider Type Main position Quantity % Market Cap.
5/22/26 Sell

Director

-3,000,000 0.2873%
1/15/26 Free

Chief Executive Officer

1,191,962 0.1142%
1/15/26 Free

Director

230,502 0.0221%
Change 5-day change 1-year change 3-year change Capi.($)
+3.23%+3.23%+39.13%+86.05% 113M
+0.01%+4.45%-14.78%-16.59% 13.79B
+1.52%-8.34%+40.09%-8.60% 3.89B
+0.06%-3.90%+64.84%+107.14% 1.2B
-3.05%-2.34%-38.13%-60.52% 1.21B
+0.19%-2.78%-41.32%-47.39% 1.09B
+0.34%+2.35%-42.93% - 934M
+2.37%-14.11%+49.28%+79.71% 457M
-4.63%+4.15%+56.59% - 345M
-0.21%+0.88%-58.49%+234.80% 262M
Average -0.02%+0.95%+5.43%+46.82% 2.33B
Weighted average by Cap. +0.12%+2.20%-3.01%-6.84%

Financials

2024 2025
Net sales 2.99M 2.08M 1.83M 1.7M 1.56M 2.93M 202M 20.34M 7.93M 98.32M 7.81M 7.65M 341M 3.72M 2.6M 2.28M 2.12M 1.95M 3.66M 251M 25.37M 9.89M 123M 9.75M 9.54M 425M
Net income -6.06M -4.22M -3.72M -3.45M -3.17M -5.95M -409M -41.28M -16.1M -200M -15.86M -15.52M -692M -6.31M -4.4M -3.87M -3.6M -3.31M -6.2M -426M -42.99M -16.77M -208M -16.52M -16.16M -721M
Net Debt -11.01M -7.68M -6.75M -6.27M -5.77M -10.82M -743M -75M -29.25M -363M -28.82M -28.19M -1.26B -3.07M -2.14M -1.88M -1.75M -1.61M -3.02M -207M -20.91M -8.16M -101M -8.04M -7.86M -351M
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
26-07-23 A$0.1600 +3.23% 383,469
26-07-22 A$0.1550 +10.71% 651,266
26-07-21 A$0.1400 -9.68% 144,373
26-07-20 A$0.1550 0.00% 171,537
26-07-17 A$0.1550 0.00% 132,048